BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:2019 Prather Lecture Series: Harmit Malik
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_1197730_0
SUMMARY:2019 Prather Lecture Series: Harmit Malik
DESCRIPTION:<p>	<drupal-media data-entity-type="media" data-entity-uuid="eef8bd9e-a499-4553-8d00-e9d924463f2a" data-align="left" alt="Harmit Malik" data-view-mode="hwp_small"></drupal-media><a data-url="https://research.fhcrc.org/malik/en/labmembers/harmitmalik.html" href="https://research.fhcrc.org/malik/en/labmembers/harmitmalik.html" title="">Harmit Malik</a><br>Principal Investigator, Fred Hutchinson Cancer Research Center<br>Investigator, Howard Hughes Medical Institute<br>Professor, University of Washington</p><p>	<a data-url="https://oeb.harvard.edu/prather-lecture-series" href="internal:/prather-lecture-series" title="">Rules of Engagement: Molecular Arms Races Between Host and Viral Genomes</a></p><p>	<!--break-->Abstract: Prof Malik studies the causes and consequences of genetic conflicts that take place between different genomes (e.g., host-virus interactions) or between components of the same genome (e.g., chromosomal competition at centromeric regions). He is interested in understanding these "molecular arms races" and how they drive recurrent genetic innovation, from the perspective of both evolutionary biology and human disease. Antagonistic interactions drive host-virus evolutionary arms-races, which often manifest as recurrent amino acid changes (<em>i.e.,</em> positive selection) at their protein-protein interaction interfaces. We investigated whether combinatorial mutagenesis of positions under positive selection in a host antiviral protein could enhance its restrictive properties. We tested ~700 variants of human MxA, generated by combinatorial mutagenesis, for their ability to restrict Thogoto orthomyxovirus (THOV), which is distantly related to the influenza A virus (IAV). We identified MxA super-restrictors with increased binding to THOV NP target protein and 10-fold higher anti-THOV restriction relative to wild-type human MxA, the most potent naturally-occurring anti-THOV restrictor identified. Our findings reveal a means to elicit super-restrictor antiviral proteins by leveraging signatures of positive selection. Although some MxA super-restrictors of THOV were impaired in their restriction of H5N1 influenza A virus (IAV), other super-restrictor variants increased THOV restriction without impairment of IAV restriction. Thus, antiviral proteins like MxA mitigate breadth-versus-specificity tradeoffs that could otherwise constrain their adaptive landscapes.</p><p>	Host: <a data-url="https://oeb.harvard.edu/people/david-haig" href="internal:/people/david-haig" title="">Haig Lab</a></p><p>	 </p>
LOCATION:Geological Museum Lecture Hall, 24 Oxford Street
STATUS:CONFIRMED
DTSTART:20191112T210000Z
DTEND:20191112T210000Z
END:VEVENT
END:VCALENDAR